NCT07670325

Brief Summary

This clinical investigation aims to evaluate the safety, feasibility, and preliminary performance of the AKO-R wearable robotic device for knee assistance during walking. The study involves participants performing treadmill and overground gait training under supervised conditions, with the device providing assistive torque to support movement. Clinical and functional outcomes are assessed using validated measurement tools, while additional data are collected to characterize user performance and interaction with the device. The study is designed as an exploratory investigation to gather evidence supporting the clinical use and further development of the device. Primary outcomes regards safety of the device and preliminary clinical benefit on gait symmetry.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable stroke

Timeline
4mo left

Started Jun 2026

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress25%
Jun 2026Nov 2026

First Submitted

Initial submission to the registry

April 30, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

June 22, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 26, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2026

Last Updated

June 26, 2026

Status Verified

June 1, 2026

Enrollment Period

5 months

First QC Date

April 30, 2026

Last Update Submit

June 24, 2026

Conditions

Keywords

exoskeletonrobotics rehabilitationstroke

Outcome Measures

Primary Outcomes (3)

  • Number of device-related adverse events

    through study completion, an average of 1 year

  • Step Length Symmetry Index Change

    The Step Length Symmetry Index (SI) will be compared across conditions. Descriptive data are averaged across \>20 steps. Score closer to 0 means a better outcome.

    Day 4

  • Stance Time Symmetry Index Change

    The Stance Time Symmetry Index (SI) will be compared across conditions. Descriptive data are averaged across \>20 steps. Score closer to 0 means a better outcome.

    Day 4

Secondary Outcomes (6)

  • Range of motion Change

    Day 4

  • Self-selected velocity Change

    Day 5

  • Endurance

    Day 5

  • Usability score

    Day 5

  • Acceptability

    Day 5

  • +1 more secondary outcomes

Study Arms (1)

Exo-Assisted

EXPERIMENTAL

Patients perform gait training on treadmill and overground with assistance of the investigational device

Device: Exo-Assisted

Interventions

Participants perform gait training assiste by the knee exoskeletn investigational device

Exo-Assisted

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • diagnosed stroke with fMRI
  • within 2 years from stroke event
  • FAC\>= 3
  • height \[1.5 - 2\]m
  • weigth \<= 100 Kg

You may not qualify if:

  • MoCA\<18
  • Pregnancy
  • Implanted cardiac devices, such as pacemakers or implantable cardioverter defibrillators (ICDs)
  • Recent or current participation in research studies that, in the opinion of the Principal Investigator, may affect the subject's response to the study intervention
  • Severe aphasia
  • MAS=4

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Don Gnocchi - Centro "S. Maria della Provvidenza"

Roma, RM, 00166, Italy

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 30, 2026

First Posted

June 26, 2026

Study Start

June 22, 2026

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

November 30, 2026

Last Updated

June 26, 2026

Record last verified: 2026-06

Locations